<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; India’s Practical Route</title>
	<atom:link href="http://www.tapanray.in/tag/indias-practical-route/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Robust Patents, Not Tweaked Monopolies: India’s Practical Route to Affordable Medicines</title>
		<link>http://www.tapanray.in/robust-patents-not-tweaked-monopolies-indias-practical-route-to-affordable-medicines/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=robust-patents-not-tweaked-monopolies-indias-practical-route-to-affordable-medicines</link>
		<comments>http://www.tapanray.in/robust-patents-not-tweaked-monopolies-indias-practical-route-to-affordable-medicines/#comments</comments>
		<pubDate>Fri, 30 May 2025 00:00:36 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[advances]]></category>
		<category><![CDATA[affordable]]></category>
		<category><![CDATA[India’s Practical Route]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[monopolies]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Robust]]></category>
		<category><![CDATA[Safeguards]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[therapeutic]]></category>
		<category><![CDATA[Tweaked]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=10902</guid>
		<description><![CDATA[In April 2025, the United States Trade Representative (USTR) released its annual Special 301 Report, once again placing India on its &#8220;Priority Watch List&#8221; for intellectual property (IP) concerns. The report highlights persistent issues, particularly in the pharmaceutical sector, citing challenges &#8230; <a href="http://www.tapanray.in/robust-patents-not-tweaked-monopolies-indias-practical-route-to-affordable-medicines/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/robust-patents-not-tweaked-monopolies-indias-practical-route-to-affordable-medicines/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
